About Chi-Fu Jeffrey Yang, MD

Dr. Chi-Fu Jeffrey Yang is a thoracic surgeon at Massachusetts General Hospital and an Assistant Professor of Surgery at Harvard Medical School.  He received his bachelor's degree in biochemistry from Harvard College and his medical degree at Harvard Medical School. He completed his general surgery residency at Duke University Medical Center and cardiothoracic surgery fellowship at Stanford University Medical Center.  

Dr. Yang practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, including using video-assisted thoracoscopic surgical (VATS), robotic, endoscopic, and bronchoscopic approaches.  Dr. Yang has received numerous awards, including recognition for exceptional accomplishment in both clinical care of patients and in the teaching of medical students. 

Dr. Yang’s research focus is in the field of thoracic oncology and he performs clinical research to try to optimize the outcomes of patients with thoracic surgical conditions. He has been the lead investigator on several high impact studies published in the Journal of Clinical Oncology, Annals of Surgery, and Chest.  He has written over 90 publications, including over 50 as first- or co-first author. Dr. Yang is a member of the editorial board of the Journal of Thoracic and Cardiovascular Surgery, the Journal of Thoracic Diseases, and the Society of Thoracic Surgeons Online Curriculum.

Dr. Yang is also focused on raising awareness of lung cancer screening. He started the American Lung Cancer Screening Initiative (ALCSI), a 501(c)(3) non-profit, which has worked with communities across 21 states to highlight the importance of lung cancer screening for high-risk individuals.  In 2020, he co-drafted a resolution, S. Res. 780, to raise awareness for lung cancer and lung cancer screening that passed in the U.S. Senate, by unanimous, bipartisan support.

When Dr. Yang is not at Mass General, he enjoys spending time with his wife, Phoebe, two daughters and his dog. 

Departments, Centers, & Programs:

Clinical Interests:



Division of Thoracic Surgery
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-5200
Fax: 617-756-7667

Medical Education

  • MD, Harvard Medical School
  • Residency, Duke University Medical Center
  • Fellowship, Stanford University Hospital

American Board Certifications

  • Surgery, American Board of Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • View my most recent publications at PubMed

    Mayne NR, Lin BK, Darling AJ, Raman V, Patel D, Liou D, D’Amico TA, Yang CJ.  Stereotactic Body Radiotherapy versus Delayed Surgery for Early Stage Non-small-cell Lung Cancer During the COVID-19 Pandemic.  Annals of Surgery 2020. [Epub ahead of print]. PMID: 33074904.

    Yang CJ, Kumar A, Klapper J, et al.  A National Analysis of Long-term Survival Following Thoracoscopic versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.  Annals of Surgery 2019. 269 (1):163-171. PMID: 28799982.

    Yang CJ, Kumar A, Deng J, et al. A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic vs Open Lobectomy for Clinical Stage II Non-small-cell Lung Cancer. Annals of Surgery 2019. [Epub ahead of print]. PMID: 30946089. 

    Yang CJ, Chan DY, Shah S, et al. Long-term Survival After Surgery Compared with Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.  Annals of Surgery 2018. 268(6):1105-1112. PMID: 28475559. 

    Yang CJ, Wang H, Kumar A, et al. Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. Chest 2017. 152(6):1239-1250. PMID: 28800867.

    Yang CJ, Chan DY, Speicher PJ, et al. Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology 2016, 34(10):1057-64. PMID: 26786925